Science Translational Medicine· Sangwoo Shawn Kim, Sayuri Miyauchi, Riley N. Jones, Elizabeth Weihe, Lin Zhang, Jamillah Murtadha, Stephen T. Ryan, Shumei Kato, Razelle Kurzrock, Jason K. Sicklick, Ezra E. W. Cohen, Sandip P. Patel, Sarah G. Boles, Kathryn A. Gold, Gregory P. Botta, Hitendra Patel, Rebecca A. Shatsky, Susan M. Kaech, Souvick Roy, P. Dominick Sanders, James D. Murphy, Christopher J. Kane, Emily I. Pittman, Jingjing Zou, Minya Pu, Natalie E. Quach, J. Silvio Gutkind, Karen Messer, Diane Simeone, Loren K. Mell, Joseph A. Califano, Christina Jamieson, Arno J. Mundt, Andrew B. Sharabi·· 16 小时前AI 评分22
B细胞亚群与不同癌症类型患者接受免疫检查点抑制治疗后的持久应答相关
B cell subsets are associated with durable responses in distinct cancer types after immune checkpoint inhibition
AI 导读
B细胞亚群与不同癌症类型患者接受免疫检查点抑制治疗后的持久应答相关。该研究发表于Science Translational Medicine，现有内容未提供具体癌种、研究设计、样本量或效应量。
来源：Science Translational Medicine · science.org